The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in ...

US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...

The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.

The U.S. government awarded Moderna $590 million in January to advance the development of its bird flu vaccine ...

American pharmaceutical company Moderna (MRNA) is reportedly under scrutiny by U.S. President Donald Trump’s team, which is ...

The FDA canceled a vaccine advisory committee meeting to discuss influenza virus strains that should be included in shots for ...

U.S. health officials are reevaluating a $590M bird flu vaccine contract that was awarded to Moderna ( NASDAQ: MRNA) by the ...

Moderna (NASDAQ: MRNA) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future. One way Moderna has been trying to appease investors and reduce its losses ...

The review is part of a government push to examine spending on messenger RNA-based vaccines, the technology that powered ...

A $590 million contract awarded to Moderna by the U.S. government to aid in vaccine development for bird flu is being ...

Moderna Inc.'s stock tumbled 4% Thursday, after a report that health officials are reviewing a contract the company won from the Biden administration to support its efforts to develop a bird-flu ...

The Trump administration confirmed it's reviewing whether to pull $590 million in funding that Moderna received in the final ...